BNP Paribas Financial Markets’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-65,510
| Closed | -$3.04M | – | 4603 |
|
|
2019
Q2 | $3.04M | Buy |
65,510
+16,458
| +34% | +$462K | 0.01% | 1267 |
|
|
2019
Q1 | $1.2M | Buy |
49,052
+32,117
| +190% | +$669K | ﹤0.01% | 1622 |
|
|
2018
Q4 | $241K | Sell |
16,935
-6,174
| -27% | -$93.7K | ﹤0.01% | 2043 |
|
|
2018
Q3 | $351K | Buy |
23,109
+2,352
| +11% | +$36K | ﹤0.01% | 2177 |
|
|
2018
Q2 | $348K | Sell |
20,757
-166,070
| -89% | -$2.64M | ﹤0.01% | 2175 |
|
|
2018
Q1 | $3.05M | Buy |
186,827
+145,976
| +357% | +$2.34M | 0.01% | 1210 |
|
|
2017
Q4 | $523K | Buy |
40,851
+22,038
| +117% | +$251K | ﹤0.01% | 2445 |
|
|
2017
Q3 | $231K | Sell |
18,813
-1,013
| -5% | -$9.41K | ﹤0.01% | 2384 |
|
|
2017
Q2 | $166K | Buy |
19,826
+17,614
| +796% | +$144K | ﹤0.01% | 2556 |
|
|
2017
Q1 | $19.8K | Sell |
2,212
-797
| -26% | -$8.48K | ﹤0.01% | 3025 |
|
|
2016
Q4 | $26.4K | Sell |
3,009
-7,079
| -70% | -$52.1K | ﹤0.01% | 3075 |
|
|
2016
Q3 | $68.1K | Buy |
10,088
+4,466
| +79% | +$17.3K | ﹤0.01% | 2290 |
|
|
2016
Q2 | $20K | Buy |
+5,622
| New | +$18.3K | ﹤0.01% | 2587 |
|
|
2016
Q1 | – | Sell |
-32,432
| Closed | -$137K | – | 3323 |
|
|
2015
Q4 | $137K | Buy |
32,432
+3,267
| +11% | +$14.9K | ﹤0.01% | 2146 |
|
|
2015
Q3 | $133K | Buy |
29,165
+17,430
| +149% | +$103K | ﹤0.01% | 2206 |
|
|
2015
Q2 | $84.6K | Buy |
11,735
+8,423
| +254% | +$62.2K | ﹤0.01% | 2170 |
|
|
2015
Q1 | $24.4K | Buy |
+3,312
| New | +$23.6K | ﹤0.01% | 2280 |
|
|
2014
Q4 | – | Sell |
-7,462
| Closed | -$26.6K | – | 3618 |
|
|
2014
Q3 | $26.6K | Buy |
+7,462
| New | +$29.4K | ﹤0.01% | 2965 |
|
|
2014
Q1 | – | Sell |
-1,515
| Closed | -$7.59K | – | 3998 |
|
|
2013
Q4 | $7.59K | Sell |
1,515
-30,308
| -95% | -$165K | ﹤0.01% | 2826 |
|
|
2013
Q3 | $198K | Sell |
31,823
-10,031
| -24% | -$59.6K | ﹤0.01% | 2269 |
|
|
2013
Q2 | $190K | Buy |
+41,854
| New | +$225K | ﹤0.01% | 2356 |
|
Other funds holding ARRY
BNP Paribas Financial Markets's ARRY Position: Q3 2019 in Review
BNP Paribas Financial Markets sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 65,510 shares — an estimated $3.04M sold.
BNP Paribas Financial Markets first reported a position in ARRY in Q2 2013 and held it in 21 quarters. The position peaked at $3.05M in Q1 2018. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- BNP Paribas Financial Markets reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- BNP Paribas Financial Markets sold 65,510 Array Biopharma Inc shares in Q3 2019, an estimated $3.04M.
- BNP Paribas Financial Markets first reported a position in Array Biopharma Inc in Q2 2013 and held it in 21 quarters.
- BNP Paribas Financial Markets's Array Biopharma Inc position peaked at $3.05M in Q1 2018.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.